Inmazeb for hemorrhagic fever, ebola

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 24 Feb 2025: Trial registered, NCT06841614

The trials

NCT06841614: EBOla Post-Exposure Prophylaxis

State
Not started
Phase
Phase 3
People
160 planned
Started
Sep 2026
Primary completion
1 Aug 2027
Arms
Ervebo + Inmazeb
Results
None posted
  1. 24 Feb 2025: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Trial registered

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.